Celloram Inc.
PrivateLast Round
Seed
Oct 16, 2020
Total Funding Raised
$9.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Celloram Inc. operates in Healthcare & Life Sciences and is based in Cleveland, Ohio. Its latest recorded funding round was a Seed round in October 2020.
Celloram Inc. is a biotechnology company that develops cell-based therapies and small molecule therapeutics for the treatment of cancer, immune disorders, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celloram Inc. Comparables
Compare Celloram Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rezq Bio | 81% | |
| Tidewave Bio | 78% | |
| Cell4Cure AB | 77% |
For institutional investors. Book with your work email.
Celloram Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Celloram Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Winvest Venture Capital | Seed |
| U.S. Department of War | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Hiring one role, representing 33% of current headcount.
- May 17, 2026
Monthly visitors grew 694% MoM to 1.3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 3, 2026
Celloram Inc., a preclinical-stage company, develops Protexi, a dendritic cell vaccine that uses SARS-CoV-2 Spike epitopes to activate CD4 and CD8 T cells against tumors, in partnership with Case Western Reserve University and University Hospitals Cleveland Medical Center in Ohio; it publishes preclinical results on Sep 3rd '26.
For institutional investors. Book with your work email.
Celloram Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Celloram Inc.'s valuation, stock price, and market status.
Is Celloram Inc. a public or private company?
Celloram Inc. is a private company.
What is the current stock price of Celloram Inc.?
Celloram Inc. is a private company, so its shares have no public market price. Caplight tracks Celloram Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Celloram Inc. worth (valuation)?
Valuation information for Celloram Inc. is not publicly available.
Can I buy Celloram Inc. stock?
Celloram Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Celloram Inc.'s last funding round?
Celloram Inc.'s most recent funding round was Seed on October 16, 2020.
Who are the main investors in Celloram Inc.?
Key investors in Celloram Inc. include Winvest Venture Capital, U.S. Department of War.
Will Celloram Inc. IPO soon?
No public IPO plans have been announced for Celloram Inc..
How can I track Celloram Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Celloram Inc.'s shares on secondary markets.